• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT Back to Search Results
Model Number 6L45-21
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 06/18/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer observed a falsely elevated total bilirubin result for one patient on an architect c4000 analyzer.The following data was provided: sample id (b)(6) initial result, on (b)(6) 2020, was 25.2 umol/l, which was reported out of the laboratory and questioned by the medical provider.The sample was then repeated in another laboratory, using an alinity c analyzer, and the result was 9.0 umol/l.There was no impact to patient management reported.
 
Additional Manufacturer Narrative
The complaint investigation for falsely elevated total bilirubin results on a pediatric sample, while using total bilirubin reagent list number 6l45, lot number 55889uq09, included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.A review of complaint activity determined that there is no atypical complaint activity for lot number 55889uq09.Trending review determined no adverse trend for falsely elevated results for the product.Return testing was not completed as returns were not available.Complaint data from the customer shows the issue is due to a suspect assay calibration, specific to the customer site.The customer recalibrated the assay and the results were lower.The qc results were also affected, however, the customer continued to generate patient results.A review of the product labeling concluded that the issue is sufficiently addressed.Manufacturing documentation for the likely cause lots were reviewed and did not identify any issues.Based on all available information and abbott diagnostics' complaint investigation, no product deficiency was identified.
 
Additional Manufacturer Narrative
The correct manufacturing site for suspect medical device total bilirubin is abbott laboratories (irving ia/cc) 1915 hurd drive irving, tx 75038 and was submitted under manufacturer report number 3016438761-2020-00183.All further information will be documented under mdr number 3016438761-2020-00183.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Common Device Name
TOTAL BILIRUBIN REAGENT
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key10267950
Report Number1415939-2020-00082
Device Sequence Number2345462
Product Code CIG
UDI-Device Identifier00380740011369
UDI-Public00380740011369
Combination Product (Y/N)N
Initial Reporter CountryHK
PMA/510(K) Number
K060574
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 08/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2021
Device Model Number6L45-21
Device Catalogue Number06L45-21
Device Lot Number55889UQ09
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/22/2020
Supplement Date Received by Manufacturer08/11/2020
08/05/2020
Initial Report FDA Received Date07/13/2020
Supplement Report FDA Received Date08/13/2020
08/18/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARCHITECT C4000 ANALYZER, LIST# 02P24-40,; ARCHITECT C4000 ANALYZER, LIST# 02P24-40,; ARCHITECT C4000 ANALYZER, LIST# 02P24-40,; SERIAL# (B)(6); SERIAL# (B)(6); SERIAL# (B)(6)
-
-